355 related articles for article (PubMed ID: 35078435)
1. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of Circadian Clock Genes as Significant Clinic Factor in the Tumorigenesis of Hepatocellular Carcinoma.
Liang Y; Wang S; Huang X; Chai R; Tang Q; Yang R; Huang X; Wang X; Zheng K
Comput Math Methods Med; 2021; 2021():8238833. PubMed ID: 34745328
[TBL] [Abstract][Full Text] [Related]
3. Research on circadian clock genes in common abdominal malignant tumors.
Qiu MJ; Liu LP; Jin S; Fang XF; He XX; Xiong ZF; Yang SL
Chronobiol Int; 2019 Jul; 36(7):906-918. PubMed ID: 31014126
[TBL] [Abstract][Full Text] [Related]
4. Research on circadian clock genes in non-small-cell lung carcinoma.
Qiu M; Chen YB; Jin S; Fang XF; He XX; Xiong ZF; Yang SL
Chronobiol Int; 2019 Jun; 36(6):739-750. PubMed ID: 31014124
[TBL] [Abstract][Full Text] [Related]
5. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
Front Immunol; 2022; 13():777724. PubMed ID: 35154101
[TBL] [Abstract][Full Text] [Related]
8. Association between circadian genes, bipolar disorders and chronotypes.
Etain B; Jamain S; Milhiet V; Lajnef M; Boudebesse C; Dumaine A; Mathieu F; Gombert A; Ledudal K; Gard S; Kahn JP; Henry C; Boland A; Zelenika D; Lechner D; Lathrop M; Leboyer M; Bellivier F
Chronobiol Int; 2014 Aug; 31(7):807-14. PubMed ID: 24716566
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility.
Benna C; Rajendran S; Spiro G; Menin C; Dall'Olmo L; Rossi CR; Mocellin S
J Transl Med; 2021 Feb; 19(1):57. PubMed ID: 33549124
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of STK11 with different mutation status and its relationship with tumor-infiltrating immune cells in non-small cell lung cancer.
Zheng J; Deng Y; Huang B; Chen X
Front Immunol; 2024; 15():1387896. PubMed ID: 38736875
[TBL] [Abstract][Full Text] [Related]
11. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Tian WJ; Liu SS; Li BR
Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
[TBL] [Abstract][Full Text] [Related]
12. Circadian clock pathway genes associated with colorectal cancer risk and prognosis.
Gu D; Li S; Ben S; Du M; Chu H; Zhang Z; Wang M; Zhang ZF; Chen J
Arch Toxicol; 2018 Aug; 92(8):2681-2689. PubMed ID: 29968159
[TBL] [Abstract][Full Text] [Related]
13. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma.
Huang Z; He A; Wang J; Lu H; Zhang R; Wu L; Feng Q
Aging (Albany NY); 2021 Jun; 13(12):16637-16655. PubMed ID: 34162762
[TBL] [Abstract][Full Text] [Related]
14. Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses.
Mao Y; Fu A; Leaderer D; Zheng T; Chen K; Zhu Y
BMC Cancer; 2013 Oct; 13():498. PubMed ID: 24161199
[TBL] [Abstract][Full Text] [Related]
15. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
[TBL] [Abstract][Full Text] [Related]
18. An association study in the Taiwan Biobank reveals RORA as a novel locus for sleep duration in the Taiwanese Population.
Hou SJ; Tsai SJ; Kuo PH; Liu YL; Yang AC; Lin E; Lan TH
Sleep Med; 2020 Sep; 73():70-75. PubMed ID: 32791442
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
Huang YT; Heist RS; Chirieac LR; Lin X; Skaug V; Zienolddiny S; Haugen A; Wu MC; Wang Z; Su L; Asomaning K; Christiani DC
J Clin Oncol; 2009 Jun; 27(16):2660-7. PubMed ID: 19414679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
